27. November 2017

LimmaTech Biologics will be attending the Annual Meeting of the Antibody Society in San Diego from 11 through 15 December 2017.

25. Oktober 2017

LimmaTech Biologics will be attending the PEGS Europe in Lisbon from 13 through 17 November 2017.

11. Oktober 2017

Award Winning Paper

LimmaTech Biologics is very pleased to announce that the paper on the “Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial” received an award from The Swiss Society for Infectious Diseases in the category “clinical research in infectious diseases”. We like to thank all the people involved in this achievement.
29. September 2017

LimmaTech Biologics will be attending the Immunogenicity & Bioassay Summit in Washington, USA from 23 through 26 October 2017.

29. September 2017

LimmaTech Biologics will be attending the Bio Europe in Berlin, Germany from 7 through 9 November 2017.

25. September 2017

LimmaTech Biologics will be attending the 2nd Human Challenge Trials Conference in Rockville, USA from 28 through 30 September 2017.

16. Juni 2017

LimmaTech Biologics will be attending the Vaccines for Enteric Diseases in Albufeira, Portugal from 9 through 11 October 2017.

16. Juni 2017

LimmaTech Biologics will be attending the World Vaccine Congress Europe in Barcelona from 10 through 12 October 2017.

Dr Amir Faridmoayer to present.
3. Mai 2017

LimmaTech Biologics will be attending the 19th EUROCARB in Barcelona from 2 through 6 July 2017.

We use cookies to make this website work better for you and to track site visits anonymously. You can opt out if you like. ­Tell me more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close